All Stories

  1. Antibody-Mediated Targeting of Secretory Protein SCUBE3 Suppresses Cancer Progression by Inhibiting Oncogenic Signaling and Inducing Anti-tumor Immunity
  2. Epigenetic silencing of DNA sensing pathway by FOXM1 blocks stress ligand-dependent antitumor immunity and immune memory
  3. Benchmarking mouse contamination removing protocols in patient-derived xenografts genomic profiling
  4. Anti-Proliferative and Apoptotic Activities of Rumex crispus
  5. Malnutrition and its associated factors among people living with HIV/AIDS (PLHIV) in resource limited settings: A single-centred study
  6. Three Decades of Novel Drug Approval: A Comprehensive Analysis
  7. Patency outcomes of primary inferior vena cava repair in radical nephrectomy and tumor thrombectomy
  8. MP28-17 ROLE OF ADJUVANT IMMUNOTHERAPY FOR PATIENTS WITH RENAL CELL CARCINOMA AT INCREASED RISK OF RECURRENCE FOLLOWING RESECTION
  9. MP47-13 A COMPARATIVE ANALYSIS OF ROBOT-ASSISTED RETROPERITONEOSCOPIC PARTIAL NEPHRECTOMY (RARPN) FOR ANTERIOR VS POSTERIOR RENAL TUMORS: A PROPENSITY SCORE MATCHED ANALYSIS IN A MULTI-INSTITUTIONAL COHORT
  10. MP50-13 OPEN VERSUS MINIMAL INVASIVE RETROPERITONEAL LYMPH NODE DISSECTION: A NATIONAL CANCER DATABASE ANALYSIS
  11. PD36-09 TIME TRENDS IN SYSTEMIC TREATMENTS AND SURVIVAL IN PATIENTS WITH METASTATIC UROTHELIAL BLADDER CANCER: OUTCOMES IN THE ERA OF IMMUNOTHERAPY
  12. Adjuvant immunotherapy for patients with renal cell carcinoma at increased risk of recurrence following resection: A National Cancer Database analysis.
  13. A comparative analysis of open vs minimal invasive lymph node dissection for testicular cancer using National Cancer Database
  14. Comparison of contemporary treatment strategies for locally advanced (stage IIIB) urothelial bladder cancer using National Cancer Database
  15. Impact of systemic treatments on overall survival in metastatic urothelial bladder cancer: A time-trend analysis
  16. Urine analysis: A convenient and strong indicator for renal function assessment in surgery for renal cancer
  17. Utility of adjuvant immunotherapy in high-risk non-metastatic renal cell carcinoma: A real-world experience using national cancer database analysis
  18. FDA approved Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices: An updated landscape
  19. FDA approved Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices: An updated 2022 landscape
  20. Production Optimization and Biochemical Characterization of Cellulase from Geobacillus sp. KP43 Isolated from Hot Spring Water of Nepal
  21. Discovery of phenanthridine analogues as novel chemical probes disrupting the binding of DNA to ΔFosB homodimers and ΔFosB/JunD heterodimers
  22. Self-assembly of the bZIP transcription factor ΔFosB